Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Radiosensitizers to increase radiotherapy efficacy

Ananya Choudhury • 2 Jun 2019
ASCO 2019
Bladder Cancer Genitourinary Cancer Cisplatin Gemcitabine Nicotinamide
BC2001 BCON

Ananya Choudhury, PhD, MRCP, FRCR, of The Christie NHS Foundation Trust, Manchester, UK, presents data from clinical trials, where radiosensitizers increase the efficacy of radiotherapy in patients with bladder carcinoma. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Ananya Choudhury

Personalized treatments in bladder cancers: future remarks
1:26
Personalized treatments in bladder cancers: future remarks
Ananya Choudhury • 2 Jun 2019
Rare urothelial cancers: what options are available?
1:02
Rare urothelial cancers: what options are available?
Ananya Choudhury • 2 Jun 2019

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026
The content of VJOncology is intended for healthcare professionals